Inferring human miRNA-disease associations via multiple kernel fusion on GCNII

Shanghui Lu1,2, Yong Liang1,3, Le Li1

  • 1School of Computer Science and Engineering, Macau University of Science and Technology, Taipa, China.

Frontiers in Genetics
|September 22, 2022
PubMed

Insights

Predicting microRNA-disease associations is crucial for drug discovery. A new method, MKFGCNII, uses graph convolutional networks and kernel fusion to accurately identify these links, achieving a high AUC of 0.9631.

Area of Science:

  • Biomedical Informatics
  • Computational Biology
  • Genomics

Background:

  • Complex human diseases are linked to microRNA (miRNA) mutations and abnormal expression.
  • miRNAs regulate biological processes, making them key targets for disease diagnosis and drug development.
  • Accurate prediction of miRNA-disease associations is vital for advancing personalized medicine.

Purpose of the Study:

  • To develop a novel computational method for predicting potential miRNA-disease associations.
  • To leverage advanced deep learning techniques for enhanced feature extraction and association prediction.
  • To provide a robust tool for identifying novel therapeutic targets and diagnostic biomarkers.

Main Methods:

  • Proposed MKFGCNII, a method employing multiple kernel fusion on a Graph Convolutional Network with Initial residual and Identity mapping (GCNII).
  • Constructed a heterogeneous network of miRNAs and diseases to extract multi-layer features using GCNII.
  • Applied multiple kernel fusion to integrate embeddings from different layers and utilized Dual Laplacian Regularized Least Squares for prediction.

Main Results:

  • The MKFGCNII method achieved a high Area Under the Curve (AUC) value of 0.9631 in predicting miRNA-disease associations.
  • Demonstrated superior performance compared to existing methods in identifying potential miRNA-disease links.
  • The developed heterogeneous network and fusion strategy effectively captured complex biological relationships.

Conclusions:

  • MKFGCNII offers a powerful and accurate approach for predicting miRNA-disease associations.
  • This method holds significant potential for accelerating drug discovery and improving disease diagnosis.
  • The findings underscore the importance of integrating network-based approaches with deep learning for biological data analysis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.0K
DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
18.3K